MedTrace Logo

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

NCT06265077 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2024-12-13

No results posted yet for this study

Summary

No randomized controlled trial evaluated the safety and efficacy of double blockade on G-CSF induced bone pain. Therefore, this study aims to evaluate the efficacy and safety of double blockade on the incidence and severity of G-CSF induced bone pain.

Conditions

Interventions

DRUG

Placebo

Placebo

DRUG

famotidine and loratadine

famotidine 20 mg once daily and loratadine 10 mg once daily

Sponsors & Collaborators

  • Noha Mansour

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-10-17
Completion
2024-10-17

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06265077 on ClinicalTrials.gov